InvestorsHub Logo
Followers 10
Posts 592
Boards Moderated 0
Alias Born 02/12/2021

Re: Joe Kaplan post# 880

Monday, 07/25/2022 4:32:49 PM

Monday, July 25, 2022 4:32:49 PM

Post# of 1152
Not lookin good for Neuro or .....a guy that is a "consultant" , .....

Time to settle with RLF and pronto ?



https://ir.stockpr.com/neurorxpharma/sec-filings-email/content/0000950142-22-002222/eh220269223_8k.htm

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On July 12, 2022, the Company received a written notification (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Registrant was not in compliance with Nasdaq Listing Rule 5450(a)(1), as the Registrant’s closing bid price for its common stock was below $1.00 per share for the last thirty (30) consecutive business days.

My opinion is reflected in my posts, and it is never advice to buy, sell or trade any securities. Do your own due diligence before purchasing anything in the stock market.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NRXP News